05:01 AM EDT, 07/21/2026 (MT Newswires) -- Oxurion (OXUR.BR) said Tuesday its unit Axiodis CRO entered into a strategic biometrics partnership with French clinical research company KYomed Innov & Ceiso. Under the agreement, Axiodis will provide clinical data management, biostatistics, statistical programming, database design, and study documentation services for several KYomed clinical development projects. The Brussels-listed biopharmaceutical company expects the collaboration to generate 110,000 euros in revenue over the next 12 months, with the potential to exceed 170,000 euros per year as the scope expands.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.